LIPO · Lipella Pharmaceuticals Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively raise substantial doubt about the Company's ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that may result from this uncertainty.”View the 10-Q filed Nov 14, 2025
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of LIPO in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns LIPO
13F quarter Mar 31, 2025| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 2,840 | 0.06% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 557,558 | 12.07% |
| Remaining | 4,060,439 | 87.87% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 4,620,837, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of LIPO
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
Jonathan H. Kaufman
13D
CIK 1959250 · Unknown · Apr 7, 2025
Item 4 purpose: none of the classified purposes
|
212,290 | ||
| 2 |
Michael B. Chancellor
13D
CIK 1959360 · Unknown · Apr 7, 2025
Item 4 purpose: none of the classified purposes
|
209,641 | ||
| 3 |
|
69,443 | ||
| 4 |
|
60,325 | ||
| 5 |
Michele Gruber
13G
CIK 1971374 · Unknown · Sep 30, 2024
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Sep 30, 2024
|
5,859 | ||
| 6 |
Tower Research Capital LLC (TRC)
13F
CIK 1533421 · Unknown · Mar 31, 2025
|
2,708 | ||
| 7 |
MAI Capital Management
13F
CIK 1040197 · Registered investment adviser · Mar 31, 2025
|
125 | ||
| 8 |
BANK OF AMERICA CORP /DE/
13F
CIK 70858 · Bank · Mar 31, 2025
|
7 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.